id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-3326-0044,FDA,FDA-2015-N-3326,BsUFA Reauthorization Public Meeting Transcript,Other,Transcript(s),2022-03-29T04:00:00Z,2022,3,2022-03-29T04:00:00Z,,2022-03-29T18:21:19Z,,0,0,0900006484fec680